Device type · PYX
Temporary Non-Roller Type Right Heart Support Blood Pump
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
PYX
Cardiovascular
Device class
Class III
FDA decisions since 2015
1
510(k), De Novo and PMA
Adverse event reports
585
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Temporary Non-Roller Type Right Heart Support Blood Pump
- Product code
- PYX
- Device class
- Class III
- Review panel
- Cardiovascular
- Regulation
- 21 CFR 870.4360
- Specialty
- Cardiology
- FDA record
- Classification database entry for PYX
Latest FDA decisions
P170011 · Decided Sep 20, 2017 · 174 days after receipt
Device type: Temporary non-roller type right heart support blood pump (PYX) · Cardiology
Reports received
585
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
168
29% of reports
Injury reports
255
44% of reports
Death reports
162
28% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 11 | 4 | 4 | 0 |
| Jan 24 | 20 | 12 | 2 | 0 |
| Feb 24 | 14 | 17 | 3 | 0 |
| Mar 24 | 23 | 10 | 1 | 0 |
| Apr 24 | 20 | 19 | 5 | 0 |
| May 24 | 26 | 39 | 5 | 0 |
| Jun 24 | 15 | 13 | 3 | 0 |
| Jul 24 | 17 | 14 | 2 | 0 |
| Aug 24 | 23 | 22 | 3 | 0 |
| Sep 24 | 114 | 235 | 56 | 0 |
| Oct 24 | 114 | 35 | 28 | 0 |
| Nov 24 | 30 | 23 | 17 | 0 |
| Dec 24 | 13 | 25 | 13 | 0 |
| Jan 25 | 18 | 9 | 8 | 0 |
| Feb 25 | 12 | 12 | 2 | 0 |
| Mar 25 | 11 | 10 | 7 | 0 |
| Apr 25 | 10 | 14 | 7 | 0 |
| May 25 | 11 | 13 | 10 | 0 |
| Jun 25 | 21 | 26 | 11 | 0 |
| Jul 25 | 15 | 22 | 3 | 0 |
| Aug 25 | 10 | 12 | 6 | 0 |
| Sep 25 | 75 | 21 | 34 | 0 |
| Oct 25 | 19 | 24 | 27 | 0 |
| Nov 25 | 9 | 11 | 11 | 0 |
| Dec 25 | 11 | 19 | 9 | 0 |
| Jan 26 | 40 | 30 | 23 | 0 |
| Feb 26 | 10 | 48 | 33 | 0 |
| Mar 26 | 25 | 42 | 30 | 0 |
| Apr 26 | 15 | 22 | 13 | 0 |
| May 26 | 11 | 17 | 6 | 0 |
| Jun 26 | 10 | 11 | 16 | 0 |
| Jul 26 | 9 | 11 | 5 | 0 |
| Aug 26 | 12 | 20 | 5 | 0 |
| Sep 26 | 13 | 17 | 9 | 0 |
| Oct 26 | 3 | 7 | 2 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Device Sensing Problem198
- Patient Device Interaction Problem127
- Adverse Event Without Identified Device or Use Problem124
- Restricted Flow rate119
- Increase in Pressure57
- Malposition of Device38
- Pumping Stopped24
- Failure to Advance20
- Application Program Problem10
- Difficult to Remove9
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions239
- Hemorrhage/Blood Loss/Bleeding106
- Hemolysis98
- Hemodynamic instability52
- Thrombosis/Thrombus38
- Thromboembolism33
- Renal Failure27
- Cardiac Arrest23
- Hematuria21
- Thrombocytopenia17
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Impella RP with SmartAssist. Product Code: 0046-0035.Open, Classified
Z-1469-2026 · Started Jan 27, 2026 · Posted by FDA Feb 27, 2026
Reason given: Differential pressure (dP) sensor in Impella RP devices may malfunction, causing sensor values to drift.
Cause as FDA categorized it: Under Investigation by firm
- Impella RP Flex with SmartAssist. Product Code: 1000323.Open, Classified
Z-1470-2026 · Started Jan 27, 2026 · Posted by FDA Feb 27, 2026
Reason given: Differential pressure (dP) sensor in Impella RP devices may malfunction, causing sensor values to drift.
Cause as FDA categorized it: Under Investigation by firm
- Impella RP. Product Code: 0046-0011.Open, Classified
Z-1471-2026 · Started Jan 27, 2026 · Posted by FDA Feb 27, 2026
Reason given: Differential pressure (dP) sensor in Impella RP devices may malfunction, causing sensor values to drift.
Cause as FDA categorized it: Under Investigation by firm
- Impella RP with SmartAssist; Product Number: 0046-0035;Open, Classified
Z-0829-2025 · Started Dec 12, 2024 · Posted by FDA Jan 15, 2025
Reason given: Optical Sensors have been damaged due to physical interaction between the inlet and another device resulting in a Placement Signal Not Reliable (PSNR) alarm and loss of Central Venous (CV) Placement Signal, Pulmonary Artery (PA) Placement Signal & Pulmonary Artery Pulse Index (PAPi) metrics. Abiomed is reinforcing...
Cause as FDA categorized it: Under Investigation by firm
- Impella RP Flex with SmartAssist; Product Number: 1000323;Open, Classified
Z-0830-2025 · Started Dec 12, 2024 · Posted by FDA Jan 15, 2025
Reason given: Optical Sensors have been damaged due to physical interaction between the inlet and another device resulting in a Placement Signal Not Reliable (PSNR) alarm and loss of Central Venous (CV) Placement Signal, Pulmonary Artery (PA) Placement Signal & Pulmonary Artery Pulse Index (PAPi) metrics. Abiomed is reinforcing...
Cause as FDA categorized it: Under Investigation by firm
- Impella Connect, software portal for online device management that allows clinicians and Impella support staff to remotely view Impella data.Open, Classified
Z-0636-2024 · Started Dec 6, 2023 · Posted by FDA Jan 4, 2024
Reason given: The following features have been disabled from the web-based portal because the FDA has not evaluated these features for safety and effectiveness: Notifications via email feature; AIC alarm color on case tile feature; Sort case tiles by AIC alarm color feature; Pump metric display on case tile feature
Cause as FDA categorized it: No Marketing Application
- Impella RP Flex with SmartAssist intracardiac microaxial blood pump, Product Number 1000323Open, Classified
Z-2281-2023 · Started Jun 29, 2023 · Posted by FDA Aug 3, 2023
Reason given: A higher than expected rate of thrombus formation or deposition has been observed. The risk is for thrombus formations or deposits on indwelling central venous lines or cannulas may break free and enter into the Impella RP Flex, resulting in reduced flow, loss of support, or hemolysis
Cause as FDA categorized it: Under Investigation by firm
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.